Ftse Mib
33.675,15
1,37%
DAX
18.254,18
1,03%
S&P 500
5.473,17
-0,25%
NASDAQ
17.721,59
-0,79%
Bitcoin
64.809,24
-0,02%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Praxis Precision Medicines Inc (PRAX) Praxis Precision Medicines Inc (PRAX) Notizie

Praxis Precision Medicines Inc

PRAX
40,11
2,42 (6,42%)
21 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/6/202422:56EDGAR2Form S-8 POS - Securities to be offered to employees in..
07/6/202400:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202400:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202423:09EDGAR2Form 8-K - Current report
20/5/202414:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/5/202414:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202414:18EDGAR2Form 8-K - Current report
12/4/202414:00GLOBEPraxis Precision Medicines to Present on Ulixacaltamide at..
05/3/202415:08EDGAR2Form S-3 - Registration statement under Securities Act of..
05/3/202413:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/3/202413:13EDGAR2Form 8-K - Current report
05/3/202413:12EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15/2/202402:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202416:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202401:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202422:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
17/1/202422:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202422:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202423:23EDGAR2Form 8-K - Current report
12/1/202423:20EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/1/202412:01EDGAR2Form 8-K - Current report
10/1/202423:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/1/202422:19GLOBEPraxis Precision Medicines, Inc. Announces Proposed Public..
10/1/202422:10EDGAR2Form 8-K - Current report
10/1/202403:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202403:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202403:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202403:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202323:23EDGAR2Form 8-K - Current report
07/12/202323:19EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
01/12/202322:33EDGAR2Form 8-K - Current report
28/11/202313:00GLOBEPraxis Precision Medicines to Showcase Largest Pipeline of..
21/11/202322:00GLOBEPraxis Precision Medicines to Present at the Piper Sandler..
16/11/202314:00GLOBEPraxis Precision Medicines Receives PRIME Designation from..
07/11/202313:37EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202313:35EDGAR2Form 8-K - Current report
07/11/202313:00GLOBEPraxis Precision Medicines Provides Corporate Update and..
06/11/202322:24EDGAR2Form 8-K - Current report
02/11/202313:00GLOBEPraxis Precision Medicines to Present at Truist Securities..
16/10/202313:09EDGAR2Form DEF 14A - Other definitive proxy statements
10/10/202313:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202313:56EDGAR2Form PRE 14A - Other preliminary proxy statements
02/10/202319:27EDGAR2Form 8-K - Current report
02/10/202319:17GLOBEPraxis Precision Medicines Provides Portfolio Update at 2023..
27/9/202322:15GLOBEPraxis Precision Medicines To Host Hybrid R&D Day on Monday,..
19/9/202316:25APSBiotech Catches Major Premarket Bid
Apertura: 34,19 Min: 33,01 Max: 41,7742
Chiusura: 37,69

La tua Cronologia

NASDAQ
PRAX
Praxis Precision Medicines
COIN
SUNCUSD
Sunrise Token
ASX
CBHN
Deferred Settlement Trad...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network